Recombinant adenovirus vectors expressing interleukin-5 and -6 specifically enhance mucosal immunoglobulin A responses in the lung

Immunology

Volumn 101, Issue 3, 2000, Pages 388-396

  Braciak, T A ^a,e   Gallichan, W S ^a   Graham, F L ^a   Richards, C D ^a   Ramsay, A J ^c   Rosenthal, K L ^a   Gauldie, J ^a,b,d  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c Biology and Environment   (Australia)

^d MCMASTER UNIVERSITY   (Canada)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 5; INTERLEUKIN 6; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNE RESPONSE; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRUS RECOMBINANT;

ADENOVIRUSES, HUMAN; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY-PRODUCING CELLS; FEMALE; GENETIC VECTORS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKINS; LUNG; MICE; MICE, INBRED C57BL; VIRAL VACCINES;

EID: 0033653061     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00116.x     Document Type: Article

References (31)

1. A three-tiered view of the role of IgA in mucosal defense
2. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A
3. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B
4. Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine
5. Analysis of Th1 and Th2 cells in murine gut-associated tissues. Frequencies of CD4+ and CD8+ T cells that secrete IFN-gamma and IL-5
6. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells
7. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells
8. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis
9. Interleukin 5 is a differentiation factor for IgA B cells
10. Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function
11. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer
12. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo
13. Adenovirus-mediated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung
14. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters
15. Use of human adenovirus-based vectors for antigen expression in animals
16. A recombinant human adenovirus vaccine against rabies
17. Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor. Comparison with other eosinophilopoietic lymphokines and identity with interleukin-5
18. Packaging capacity and stability of human adenovirus type 5 vectors
19. Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene
20. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia
21. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract
22. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells
23. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter
24. Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo
25. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase
26. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
27. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung
28. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response
29. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
30. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo
31. Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors